Position in OGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,905,898
-$17,659,442 QoQ
Shares Held
318,180
-75.8% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $691,078,789 across 12 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,031,961 | $262,087,135 | |
| 2 | ABBV |
AbbVie Inc.
|
702,907 | $176,879,517 | |
| 3 | MRK |
Merck & Co., Inc.
|
798,048 | $102,549,168 | |
| 4 | LLY |
ELI LILLY & Co
|
38,616 | $46,317,192 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
741,187 | $42,707,194 | |
| 6 | GSK |
GSK plc
|
603,902 | $31,656,542 | |
| 7 | NVS |
Novartis AG
|
89,587 | $14,040,074 | |
| 8 | NVO |
Novo Nordisk A S
|
148,940 | $7,140,183 |
All Filings in OGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,905,898 | 318,180 | Shares | Defined | 2026-05-14 | |
| 2025-03-31 | $19,565,340 | 1,313,992 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,742,915 | 91,109 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $871,323 | 46,347 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $888,084 | 61,587 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $910,202 | 52,431 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $5,229,666 | 223,490 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $9,444,548 | 270,385 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $481,062 | 14,671 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,469,341 | 147,698 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||